Suppr超能文献

相似文献

1
Bioavailability and absorption kinetics of nicotine following application of a transdermal system.
Br J Clin Pharmacol. 1993 Sep;36(3):221-7. doi: 10.1111/j.1365-2125.1993.tb04221.x.
2
Comparison of the nicotine pharmacokinetics of Nicoderm (nicotine transdermal system) and half-hourly cigarette smoking.
J Clin Pharmacol. 1995 Oct;35(10):985-9. doi: 10.1002/j.1552-4604.1995.tb04014.x.
3
Single- and multiple-dose pharmacokinetics of Nicoderm (Nicotine Transdermal System).
J Clin Pharmacol. 1993 Feb;33(2):169-74. doi: 10.1002/j.1552-4604.1993.tb03939.x.
5
Pharmacokinetic disposition of multiple-dose transdermal nicotine in healthy adult smokers.
Pharm Res. 1992 Nov;9(11):1451-5. doi: 10.1023/a:1015862930096.
6
Transdermal nicotine substitution: pharmacokinetics of nicotine and cotinine.
Int J Clin Pharmacol Ther Toxicol. 1993 Sep;31(9):417-21.
7
An oral formulation of nicotine for release and absorption in the colon: its development and pharmacokinetics.
Br J Clin Pharmacol. 1999 Oct;48(4):485-93. doi: 10.1046/j.1365-2125.1999.00057.x.
9
Stable isotope method for studying transdermal drug absorption: the nicotine patch.
Clin Pharmacol Ther. 1991 Sep;50(3):286-93. doi: 10.1038/clpt.1991.138.

引用本文的文献

1
Transdermal Nicotine Poisoning: A Rare Case Report of Occupational Exposure.
Toxics. 2023 May 17;11(5):464. doi: 10.3390/toxics11050464.
3
Nicotine Population Pharmacokinetics in Healthy Smokers After Intravenous, Oral, Buccal and Transdermal Administration.
Clin Pharmacokinet. 2021 Apr;60(4):541-561. doi: 10.1007/s40262-020-00960-5. Epub 2020 Dec 23.
4
Nicotinic receptor modulation of the default mode network.
Psychopharmacology (Berl). 2021 Feb;238(2):589-597. doi: 10.1007/s00213-020-05711-9. Epub 2020 Nov 20.
5
Effects of smoking cessation on biological monitoring markers in urine.
Genes Environ. 2020 Sep 11;42:26. doi: 10.1186/s41021-020-00165-z. eCollection 2020.
6
Attention-enhancing effects of propranolol and synergistic effects with nicotine.
Cogn Affect Behav Neurosci. 2020 Jun;20(3):658-668. doi: 10.3758/s13415-020-00794-5.
7
Comprehensive Parent-Metabolite PBPK/PD Modeling Insights into Nicotine Replacement Therapy Strategies.
Clin Pharmacokinet. 2020 Sep;59(9):1119-1134. doi: 10.1007/s40262-020-00880-4.
8
Evidence for positive allosteric modulation of cognitive-enhancing effects of nicotine in healthy human subjects.
Psychopharmacology (Berl). 2020 Jan;237(1):219-230. doi: 10.1007/s00213-019-05363-4. Epub 2019 Nov 4.
9
Systemic Toxicity of Smokeless Tobacco Products in Mice.
Nicotine Tob Res. 2019 Jan 1;21(1):101-110. doi: 10.1093/ntr/ntx230.
10
Population pharmacokinetic model of transdermal nicotine delivered from a matrix-type patch.
Br J Clin Pharmacol. 2017 Dec;83(12):2709-2717. doi: 10.1111/bcp.13393. Epub 2017 Sep 6.

本文引用的文献

1
Single- and multiple-dose pharmacokinetics of Nicoderm (Nicotine Transdermal System).
J Clin Pharmacol. 1993 Feb;33(2):169-74. doi: 10.1002/j.1552-4604.1993.tb03939.x.
2
Steady-state pharmacokinetics and dose relationship of nicotine delivered from Nicoderm (Nicotine Transdermal System).
J Clin Pharmacol. 1993 Feb;33(2):161-8. doi: 10.1002/j.1552-4604.1993.tb03938.x.
5
New method for calculating the intrinsic absorption rate of drugs.
J Pharm Sci. 1968 Jun;57(6):918-28. doi: 10.1002/jps.2600570602.
6
Drug accumulation.
J Clin Pharmacol J New Drugs. 1967 Mar-Apr;7(2):84-8. doi: 10.1002/j.1552-4604.1967.tb00290.x.
7
Influence of tobacco abstinence on the disposition kinetics and effects of nicotine.
Clin Pharmacol Ther. 1987 Apr;41(4):474-9. doi: 10.1038/clpt.1987.59.
8
Cyclosporin-phenytoin interaction: re-evaluation using metabolite data.
Br J Clin Pharmacol. 1987 Sep;24(3):329-34. doi: 10.1111/j.1365-2125.1987.tb03177.x.
10
Pharmacokinetics of multiple daily transdermal doses of nicotine in healthy smokers.
Pharm Res. 1991 Mar;8(3):385-8. doi: 10.1023/a:1015810019076.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验